- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Sodium ion.
Displaying page 1 of 1.
EudraCT Number: 2018-001402-28 | Sponsor Protocol Number: EII_Prep | Start Date*: 2019-01-28 |
Sponsor Name:Hospital Universitario La Paz | ||
Full Title: PROTOCOL FOR THE OPTIMIZATION OF THE PREPARATION FOR THE COLONOSCOPY IN PATIENTS WITH INTESTINAL INFLAMMATORY DISEASE | ||
Medical condition: preparation in patients with inflammatory bowel disease who will undergo an endoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024225-20 | Sponsor Protocol Number: 301110_PALANCE | Start Date*: 2014-08-22 |
Sponsor Name:University Hospital Munich, Germany | ||
Full Title: The impact of phosphate balanced cristalloid infusion on acid-base homeostastis | ||
Medical condition: This study aims to investigate a new crystalloid fluid therapy regime for the perioperative setting providing stable fluid and acid-base homeostasis in the patient. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001846-24 | Sponsor Protocol Number: 1 | Start Date*: 2016-06-29 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Metabolism of Isotonic versus Hypotonic Maintenance Solutions in fasting healthy Adults (MIHMoSA), a Single-Blind Randomized Crossover Trial | ||
Medical condition: Healthy adult volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016043-19 | Sponsor Protocol Number: HIPSTER | Start Date*: 2010-04-12 |
Sponsor Name:Charité – University Medicine Berlin | ||
Full Title: Impact of a balanced infusion solution compound of 50% cristalloid and 50% colloid versus a unbalanced infusion solution of 100% cristalloid within a goal-directed hemodynamic protocol on acid-base... | ||
Medical condition: Patients undergoing elective hip replacement surgery will be divided into two groups. In one group an intravenous application of Ringer Baxter Infusionsloesung, in the other group a parallel intra... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000791-42 | Sponsor Protocol Number: JVM-GLU-12 | Start Date*: 2012-07-26 |
Sponsor Name:FUNDACION INVESTIGACION BIOMEDICA HOSPITAL UNIVERSITARIO LA PRINCESA | ||
Full Title: OPEN, RANDOMIZED AND CONTROLLED STUDY OF SAFETY AND VIABILITY, TO EVALUATE THE NEUROPROTECTIVE EFFECT OF PLASMA GLUTAMATE DIALYSIS IN ACUTE ISCHEMIC STROKE. | ||
Medical condition: BRAIN ISCHEMIC STROKE IN ACUTE PHASE | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001795-34 | Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20 | Start Date*: 2023-01-30 | |||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children | |||||||||||||
Medical condition: Preservation of hearts prior to heart transplantation in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000144-21 | Sponsor Protocol Number: UCL/10/0299 | Start Date*: 2011-10-05 | |||||||||||||||||||||
Sponsor Name:University College London | |||||||||||||||||||||||
Full Title: ION– Is ablative radiOiodine Necessary for low risk differentiated thyroid cancer patients | |||||||||||||||||||||||
Medical condition: Patients with differentiated thyroid cancer who are classed as low risk | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003309-24 | Sponsor Protocol Number: 2013-562 | Start Date*: 2013-10-28 | |||||||||||
Sponsor Name:Grete Andersen | |||||||||||||
Full Title: Lamotrigine as treatment of Myotonia | |||||||||||||
Medical condition: Myotonia is a symptom seen certain inherited muscle dystrophies and pure channelopathies (Dystrophia myotonica type 1 and 2, Myotonia Congenita, Paramyotonia Congenita, Hyperkalæmisk periodic paral... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002582-35 | Sponsor Protocol Number: MCI-196-E16 | Start Date*: 2013-03-14 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation (MTPC) | |||||||||||||
Full Title: A Multi-centre, Open-label Study Evaluating the Safety and Tolerability of Colestilan (MCI-196) in Paediatric Subjects with Chronic Kidney Disease Stages 3b to 5 and with Hyperphosphataemia not on ... | |||||||||||||
Medical condition: Hyperphosphataemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002581-12 | Sponsor Protocol Number: MCI-196-E14 | Start Date*: 2013-03-14 | |||||||||||
Sponsor Name:Mitsubishi Tanabe Pharma Corporation (MTPC) | |||||||||||||
Full Title: A Multi-centre, Randomised, Controlled, Parallel Group, Open-label Study Evaluating the Efficacy, Safety and Tolerability of Three Doses of Colestilan (MCI-196) Compared to Standard Therapy with a ... | |||||||||||||
Medical condition: Hyperphosphataemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
